Treatment Selection and Sequencing Strategies in HER2+ Metastatic Breast Cancer : Episode 8

Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine

April 7, 2025

Opinion

Video

Experts discuss how, there is a role for SRS in treating brain metastases such as if a patient were to have a large singular brain metastasis that is causing symptoms such as seizures of neurological decline, that SRS could be a warranted treatment.

EP: 1.Treatment Selection and Sequencing in Third Line Settings and Beyond

EP: 2.Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

EP: 3.Managing Toxicity in Later-Line HER2+ mBC Treatments: Real-World Insights and Mitigation Strategies for Optimal Patient QOLs

EP: 4.Supporting HER2+ mBC Patients in Later Lines: AE Management and the Role of the Multidisciplinary Team

EP: 5.Treatment Goals, Side Effects, and Supportive Care Strategies for Patients and Caregivers with HER2+ BC

EP: 6.Barbara's Story: Navigating HER2+ MBC with Brain Metastases & Tucatinib-Based Treatment in the Second-Line Setting

EP: 7.Evolving Treatment Strategies in Early HER2+ Breast Cancer

Now Viewing

EP: 8.Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine

EP: 9.Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

Video content above is prompted by the following:

What role can Stereotactic Radiosurgery (SRS) treatment have in this patient case.

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!